Related Experiment Video
Updated: Feb 25, 2026

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
Published on: December 27, 2024
Intranasal mast cell tumor in the dog: A case series
Alison Khoo1, Amy Lane1, Ken Wyatt1
1Western College of Veterinary Medicine - Internal Medicine, 106-102 Kingsmere Place, Saskatoon, Saskatchewan S7J 2K3.
Abstract:
The medical records of 4 dogs with histologically confirmed intranasal mast cell tumors (MCTs) were retrospectively evaluated to determine their biological behavior. Information on signalment, presenting clinical signs, tumor grade, treatment administered, and survival times was obtained from the medical record. All 4 patients had high grade tumors and received chemotherapy. Survival times ranged from 27 to 134 days. All 4 dogs showed signs of local or distant disease progression, suggestive of an aggressive behavior of intranasal MCTs.

